Literature DB >> 23639412

Percutaneous sclerotherapy of sialoceles after parotidectomy with fibrin glue, OK-432, and bleomycin.

Wei-liang Chen1, Li-ping Zhang, Zhi-quan Huang, Bin Zhou.   

Abstract

We evaluated the curative effect of fibrin glue combined with OK-432 (streptococcal pyrogenic exotoxin A, Picibanil™) and bleomycin on 9 patients with sialoceles after parotidectomy. The primary lesions included pleomorphic adenomas in 6 cases and Warthin's tumours in 3 cases. After a sialocele had been diagnosed each patient had repeated aspirations and pressure dressings for 3-4 weeks, but these treatments failed. The patients were then treated with percutaneous sclerotherapy with the injection of fibrin glue 8-10 ml combined with OK-432 5 mg and bleomycin 15 mg. All the sialoceles disappeared completely after a single procedure in 2-3 weeks. The patients have been followed up for more than 6 months with no evidence of recurrent sialocele or injury to the facial nerve related to sclerotherapy. This simple, safe technique can be successfully used to treat sialoceles after parotidectomy.
Copyright © 2013 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bleomycin; Fibrin glue; OK-432; Parotidectomy; Sialocele

Mesh:

Substances:

Year:  2013        PMID: 23639412     DOI: 10.1016/j.bjoms.2013.04.003

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  2 in total

1.  Management of an unusual case of iatrogenic parotid sialocele using an infant feeding tube: a novel approach.

Authors:  Ambadas Kulkarni; Soumithran Chandrasala; Basavaraj S Nimbeni; Surendar Pal Singh; Shruti Golai
Journal:  BMJ Case Rep       Date:  2014-10-19

2.  Compression Dressing Using Dental Impression Compound for Conservative Management of Sialocele.

Authors:  Adarsh Kudva; K M Carriappa; Abhay Kamath; A Chithra
Journal:  J Maxillofac Oral Surg       Date:  2016-04-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.